Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.

Walwaikar, Pradeep P; Kulkarni, Sujay S; Bargaje, Rahul S

Walwaikar, Pradeep P; Kulkarni, Sujay S; Bargaje, Rahul S.

J Indian Med Assoc ; 2005 Oct; 103(10): 559-60

Article in En | IMSEAR | ID: sea-103255

ABSTRACT

ABSTRACT

The ENGIP-I study was conducted to investigate the efficacy, and safety of itopride in patients of gastro-oesophageal reflux disease. There were significant reductions in heartburn frequency, heartburn severity, gastro-oesophageal regurgitation frequency at day 3 only. ENGIP-I study concluded that itopride was well tolerated by patients and appears to be the drug of choice in patients with gastro-oesophageal reflux disease.

Subject(s)

Adolescent; Adult; Aged; Benzamides/adverse effects; Benzyl Compounds/adverse effects; Female; Gastric Emptying/drug effects; Gastroesophageal Reflux/drug therapy; Heartburn/drug therapy; Humans; India; Male; Middle Aged; Safety; Treatment Outcome

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Safety / Benzamides / Benzyl Compounds / Aged / Female / Humans / Male / Gastroesophageal Reflux / Adolescent / Treatment Outcome Type of study: Clinical_trials Country/Region as subject: Asia Language: En Journal: J Indian Med Assoc Year: 2005 Type: Article

Fulltext

Add to My VHL

XML

Search on Google